Chemerin plasma levels are increased in COVID-19 patients and are an independent risk factor of mortality

BackgroundChemerin is an extracellular protein with chemotactic activities and its expression is increased in various diseases such as metabolic syndrome and inflammatory conditions. Its role in lung pathology has not yet been extensively studied but both known pro- and anti-inflammatory properties...

Полное описание

Библиографические подробности

Главные авторы:	Philomène Lavis, Sofia Morra, Carmen Orte Cano, Nurhan Albayrak, Véronique Corbière, Véronique Olislagers, Nicolas Dauby, Véronique Del Marmol, Arnaud Marchant, Christine Decaestecker, Françoise Mascart, Nathalie De Vos, Philippe Van de Borne, Isabelle Salmon, Myriam Remmelink, Marc Parmentier, Alessandra Kupper Cardozo, Benjamin Bondue
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Frontiers Media S.A. 2022-08-01
Серии:	Frontiers in Immunology
Предметы:	COVID-19 chemerin ChemR23 CMKLR1 survival ARDS
Online-ссылка:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.941663/full
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!